Email Print this page Bookmark this page

Learn More About LACRISERT®

Don’t miss out on any important information. Sign up today to receive free materials about LACRISERT®, including the latest news and updates.

Enter your information in the fields below:

Zip Code*
Professional designation
* Indicates required information.
YES, I would like Valeant Ophthalmics to send me periodic updates about LACRISERT®.

Protecting Your Privacy
In order to provide you with a better Web site experience and better features in the future, we ask you for your e-mail address. If you provide this data, you agree to allow Valeant to link your e-mail address to anonymous (non−personally-identifiable) information that you may have given us previously, or that may have been collected on other Valeant Web sites. We will not sell your e-mail address, and you will not receive e-mail from us that you have not agreed to receive.

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

sample request using Lacrisert video patient tip sheet
©2012 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC          Bridgewater, NJ 08807